pamogu
12/03/15 10:39
Ha respondido al tema Farmas USA
Ir a respuesta
EXEL
¿alguno la sigue o está comprado?
¿como veis la caida del 10%?
Sheff @SheffStation · 40 min Hace 40 minutos
$EXEL..$2.65 is a bloated stock w/ large O/S but has top-line METEOR Ph3 data in RCC expected 2Q15. Also PDUFA in Aug w/ priority review.
TheStreet Quant Ratings rates Exelixis as a sell. The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself, weak operating cash flow and feeble growth in its earnings per share.
http://www.thestreet.com/story/13077156/1/exelixis-exel-highlighted-as-weak-on-high-volume.html?puc=tradrdaily&cm_ven=TRADRDAILY&utm_source=dlvr.it&utm_medium=twitter